- NHC/Iron cooperative catalysis: Aerobic oxidative esterification of aldehydes with phenols
-
An NHC/iron cooperative catalytic system mediates the aerobic oxidative esterification of aldehydes with phenols. The use of equimolar amounts of reactants led to good to excellent isolated yields of esters.
- Reddy, R. Sudarshan,Rosa, Joao N.,Veiros, Luis F.,Caddick, Stephen,Gois, Pedro M. P.
-
-
Read Online
- Preparation method for synthesis of phenolic ester through thiocarboxylic acid mediated visible light catalyzed phenol acylation reaction
-
The invention discloses a preparation method for synthesis of phenolic ester through a thiocarboxylic acid mediated visible light catalyzed phenol acylation reaction. Thiocarboxylic acid compounds andphenol compounds are subjected to a site specific reaction under certain conditions to produce phenolic ester compounds, wherein the certain conditions are as follows: under the conditions of normaltemperature, normal pressure and visible light, K2CO3 is used as an alkaline catalyst, terpyridyl ruthenium dichloride hexahydrate is used as a photosensitizer and acetonitrile is used as a reaction solvent. Synthesis of phenolic ester under catalysis of visible light is realized, thiocarboxylic acid is used as an acylation reagent, and the site specific phenol esterification reaction is realizedefficiently under mild conditions of normal temperature, normal pressure and visible light. The method has mild reaction conditions, large substrate functional group tolerance, high applicability andhigh yield, and an efficient, reliable and economical preparation method is provided for synthesis of phenolic ester.
- -
-
Paragraph 0017; 0018; 0023; 0024; 0025
(2018/07/30)
-
- Study on the aromatic transesterification reaction catalyzed by phosphotungstic acid
-
A practical phosphotungstic acid-catalyzed aromatic transesterification reaction for the preparation of aryl benzoates has been developed. The transesterification method avoids the oxidation of the corresponding phenols to quinone compounds with easy operations, environmentally benign conditions and high yields of the products. It is noteworthy that in this process phosphotungstic acid can be reused and recycled.
- He, Hong-Qiang,Chang, Yu-Wei,Xu, Wei-Ming
-
supporting information
p. 280 - 282
(2015/06/22)
-
- Efficient and catalyst-free condensation of acid chlorides and alcohols using continuous flow
-
An efficient, catalyst-free continuous flow procedure for the condensation of acid chlorides and alcohols was developed. Different esters could be obtained using this protocol with excellent conversions starting from the corresponding acid chlorides and alcohols in very short reaction times (5-7 min). The reaction was performed solventless for liquid reagents but requires a solvent for solid reagents in order to prevent clogging of the microreactor. Since no catalyst is needed, the purification of the reaction mixture is very straightforward. Scale-up of the reaction to a microreactor with an internal volume of 13.8 ml makes it possible to produce 2.2 g min-1 of ester with an isolated yield of 98% and recuperation of the formed HCl.
- Van Waes, Frederik E. A.,Cukalovic, A.,Stevens, Christian V.,Drabowicz, J.
-
p. 2776 - 2779,4
(2020/09/14)
-
- NHC-iron-catalyzed aerobic oxidative aromatic esterification of aldehydes using boronic acids
-
(Figure presented) NHC-iron complexes prepared in situ very efficiently afforded benzoates via the aerobic oxidative aromatic esterification of aldehydes with boronic acids. This method uses equimolar amounts of both the aldehyde and the boronic acid allo
- Rosa, Joao N.,Reddy, R. Sudarshan,Candeias, Nuno R.,Cal, Pedro M. S. D.,Gois, Pedro M. P.
-
supporting information; experimental part
p. 2686 - 2689
(2010/09/03)
-
- Sensitivity test to predict efficacy of anti-cancer therapies
-
The present disclosure provides methods for determining the sensitivity of cancerous cells to various anti-cancer therapies and predicting the efficacy of these therapies. Specifically, the present disclosure provides methods for predicting the efficacy of one or more candidate anti-cancer therapies in a patient, based on determining the sensitivity of the patient's cancerous cells after exposure to candidate anti-cancer therapies in vitro. The disclosure further provides methods for predicting the efficacy of candidate anti-cancer therapies by using an in vitro sensitivity test of the patient's cancerous cells and a surrogate in vivo efficacy test of the patient's cancerous cells grafted into a surrogate host. The disclosure further provides methods for selecting the most efficacious anti-cancer therapy(s) for a patient, thereby avoiding ineffective or unnecessary treatments.
- -
-
-